Literature DB >> 30998900

Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.

Julia K Nussbacher1, Ricardos Tabet2, Gene W Yeo3, Clotilde Lagier-Tourenne4.   

Abstract

RNA binding proteins are critical to the maintenance of the transcriptome via controlled regulation of RNA processing and transport. Alterations of these proteins impact multiple steps of the RNA life cycle resulting in various molecular phenotypes such as aberrant RNA splicing, transport, and stability. Disruption of RNA binding proteins and widespread RNA processing defects are increasingly recognized as critical determinants of neurological diseases. Here, we describe distinct mechanisms by which the homeostasis of RNA binding proteins is compromised in neurological disorders through their reduced expression level, increased propensity to aggregate or sequestration by abnormal RNAs. These mechanisms all converge toward altered neuronal function highlighting the susceptibility of neurons to deleterious changes in RNA expression and the central role of RNA binding proteins in preserving neuronal integrity. Emerging therapeutic approaches to mitigate or reverse alterations of RNA binding proteins in neurological diseases are discussed.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  ALS; FMRP; RNA binding protein; Repeat expansion; SMA; SMN; TDP-43; autism; dementia; hnRNP

Mesh:

Substances:

Year:  2019        PMID: 30998900      PMCID: PMC6545120          DOI: 10.1016/j.neuron.2019.03.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  445 in total

1.  Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.

Authors:  Shanye Yin; Rodrigo Lopez-Gonzalez; Ryan C Kunz; Jaya Gangopadhyay; Carl Borufka; Steven P Gygi; Fen-Biao Gao; Robin Reed
Journal:  Cell Rep       Date:  2017-06-13       Impact factor: 9.423

2.  Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.

Authors:  X C Fan; J A Steitz
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

3.  The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.

Authors:  Kaalak Reddy; Bita Zamiri; Sabrina Y R Stanley; Robert B Macgregor; Christopher E Pearson
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

4.  A yeast functional screen predicts new candidate ALS disease genes.

Authors:  Julien Couthouis; Michael P Hart; James Shorter; Mariely DeJesus-Hernandez; Renske Erion; Rachel Oristano; Annie X Liu; Daniel Ramos; Niti Jethava; Divya Hosangadi; James Epstein; Ashley Chiang; Zamia Diaz; Tadashi Nakaya; Fadia Ibrahim; Hyung-Jun Kim; Jennifer A Solski; Kelly L Williams; Jelena Mojsilovic-Petrovic; Caroline Ingre; Kevin Boylan; Neill R Graff-Radford; Dennis W Dickson; Dana Clay-Falcone; Lauren Elman; Leo McCluskey; Robert Greene; Robert G Kalb; Virginia M-Y Lee; John Q Trojanowski; Albert Ludolph; Wim Robberecht; Peter M Andersen; Garth A Nicholson; Ian P Blair; Oliver D King; Nancy M Bonini; Vivianna Van Deerlin; Rosa Rademakers; Zissimos Mourelatos; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

5.  ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis.

Authors:  Matthew J Greenway; Peter M Andersen; Carsten Russ; Sean Ennis; Susan Cashman; Colette Donaghy; Victor Patterson; Robert Swingler; Dairin Kieran; Jochen Prehn; Karen E Morrison; Andrew Green; K Ravi Acharya; Robert H Brown; Orla Hardiman
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

6.  Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.

Authors:  Lin Guo; Hong Joo Kim; Hejia Wang; John Monaghan; Fernande Freyermuth; Julie C Sung; Kevin O'Donovan; Charlotte M Fare; Zamia Diaz; Nikita Singh; Zi Chao Zhang; Maura Coughlin; Elizabeth A Sweeny; Morgan E DeSantis; Meredith E Jackrel; Christopher B Rodell; Jason A Burdick; Oliver D King; Aaron D Gitler; Clotilde Lagier-Tourenne; Udai Bhan Pandey; Yuh Min Chook; J Paul Taylor; James Shorter
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

7.  Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.

Authors:  Sami J Barmada; Shulin Ju; Arpana Arjun; Anthony Batarse; Hilary C Archbold; Daniel Peisach; Xingli Li; Yuxi Zhang; Elizabeth M H Tank; Haiyan Qiu; Eric J Huang; Dagmar Ringe; Gregory A Petsko; Steven Finkbeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 8.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

9.  Stress induces tRNA cleavage by angiogenin in mammalian cells.

Authors:  Hanjiang Fu; Junjun Feng; Qin Liu; Fang Sun; Yi Tie; Jie Zhu; Ruiyun Xing; Zhixian Sun; Xiaofei Zheng
Journal:  FEBS Lett       Date:  2008-12-27       Impact factor: 4.124

10.  Systematic discovery of structural elements governing stability of mammalian messenger RNAs.

Authors:  Hani Goodarzi; Hamed S Najafabadi; Panos Oikonomou; Todd M Greco; Lisa Fish; Reza Salavati; Ileana M Cristea; Saeed Tavazoie
Journal:  Nature       Date:  2012-04-08       Impact factor: 49.962

View more
  65 in total

Review 1.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 2.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 3.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

4.  TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Authors:  Mauro Montalbano; Salome McAllen; Filippa Lo Cascio; Urmi Sengupta; Stephanie Garcia; Nemil Bhatt; Anna Ellsworth; Eric A Heidelman; Omar D Johnson; Samantha Doskocil; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2020-10-14       Impact factor: 5.996

5.  Structural basis of the zinc-induced cytoplasmic aggregation of the RNA-binding protein SFPQ.

Authors:  Jie Huang; Mitchell Ringuet; Andrew E Whitten; Sofia Caria; Yee Wa Lim; Rahul Badhan; Victor Anggono; Mihwa Lee
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

6.  TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression.

Authors:  Josiah J Herzog; Weijin Xu; Mugdha Deshpande; Reazur Rahman; Hannah Suib; Avital A Rodal; Michael Rosbash; Suzanne Paradis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

Review 7.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

8.  miR-142-3p regulates cortical oligodendrocyte gene co-expression networks associated with tauopathy.

Authors:  Jason D Hinman; Kathie J Ngo; Deborah Kim; Cidi Chen; Carmela R Abraham; Mohsen Ghanbari; M Arfan Ikram; Steven A Kushner; Riki Kawaguchi; Giovanni Coppola; Kerstin Goth; Saverio Bellusci; Israel Hernandez; Kenneth S Kosik; Brent L Fogel
Journal:  Hum Mol Genet       Date:  2021-03-25       Impact factor: 6.150

9.  Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.

Authors:  Emanuele Buratti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  In vivo 5-ethynyluridine (EU) labelling detects reduced transcription in Purkinje cell degeneration mouse mutants, but can itself induce neurodegeneration.

Authors:  Lisanne J Van't Sant; Joshua J White; Jan H J Hoeijmakers; Wilbert P Vermeij; Dick Jaarsma
Journal:  Acta Neuropathol Commun       Date:  2021-05-21       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.